Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020221358 - CRYSTAL FORM OF WEE1 INHIBITOR COMPOUND AND USE THEREOF

Publication Number WO/2020/221358
Publication Date 05.11.2020
International Application No. PCT/CN2020/088451
International Filing Date 30.04.2020
IPC
C07D 471/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
C07D 487/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61K 31/4162 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4151,2-Diazoles
4162condensed with heterocyclic ring systems
A61K 31/439 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
439the ring forming part of a bridged ring system, e.g. quinuclidine
A61K 31/496 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
Applicants
  • 石家庄智康弘仁新药开发有限公司 SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO, LTD. [CN]/[CN]
Inventors
  • 钱文远 QIAN, Wenyuan
  • 杨纯道 YANG, Chundao
  • 李正伟 LI, Zhengwei
  • 李婕 LI, Jie
  • 黎健 LI, Jian
  • 陈曙辉 CHEN, Shuhui
Agents
  • 上海弼兴律师事务所 SHANGHAI BESHINING LAW OFFICE
Priority Data
201910364694.X30.04.2019CN
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) CRYSTAL FORM OF WEE1 INHIBITOR COMPOUND AND USE THEREOF
(FR) FORME CRISTALLINE D'UN COMPOSÉ INHIBITEUR DE WEE1 ET SON UTILISATION
(ZH) Wee1抑制剂化合物的晶型及其应用
Abstract
(EN)
Disclosed is a crystal form of a compound of formula (I) and the use of the crystal form in the preparation of a drug for treating Wee1-related diseases.
(FR)
L'invention concerne une forme cristalline d'un composé de formule (I) et l'utilisation de la forme cristalline dans la préparation d'un médicament pour le traitement de maladies liées à Wee1.
(ZH)
本发明公开了式(Ⅰ)化合物的晶型,以及其晶型在制备治疗Wee1相关疾病的药物中的应用。
Latest bibliographic data on file with the International Bureau